Navigation Links
Fuld & Company Announces Appointment of MIT Fellow to Head Pharmaceutical Team's Strategic Gaming and Consulting Services
Date:12/16/2008

CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Fuld & Company today announced that Wayne Rosenkrans, Ph.D., will join the Company as vice president consulting, specializing in strategic gaming for the pharmaceutical and healthcare industries.

"We are excited to have Dr. Rosenkrans join the Fuld team," said Leonard Fuld, president. "His extensive accomplishment in the global pharmaceutical industry; government and academia -- coupled with his involvement on the cutting edge of personalized medicine -- makes him an extraordinary asset for our clients."

Fuld & Company's Pharmaceuticals Practice provides all levels of competitive support from research to consulting. The firm has serviced over 100 biotech, pharmaceutical and diagnostics/device companies for training, custom research, and systems consulting needs. Fuld assesses new product progress from early-stage development to product launch, technology partnerships between biotech and big pharma, as well as changing global technologies, regulations, and markets. The firm has researched over 60 different therapeutic categories worldwide.

Rosenkrans is a Distinguished Fellow at the Center for Biomedical Innovation at MIT working on healthcare strategy and policy issues related to science and medicine. He is also Chairman, President and a member of the board of directors of the Personalized Medicine Coalition, a Washington DC-based organization working with government and other agencies on evolving healthcare policy for Personalized Healthcare. He is also Chief Applications Officer for SciTech Strategies, focusing on scientific competency and capacity development for academia and industry.

Previously, Rosenkrans served as Director of External Relations for the Personalized Healthcare Team and Evidence-based Medicine (EBM) at AstraZeneca where he had responsibility for long-range external relations strategy and policy development. He has presented at numerous forums on aspects of personalized healthcare, evidence-based medicine, new development paradigms, and strategy development.

Rosenkrans holds an S.B. in Biology from MIT, a Ph.D. in Cell and Molecular Biology from Boston University, and received post-doctoral training in Cancer and Radiation Biology at the University of Rochester.

Fuld & Company, based in Cambridge, Mass., with offices in London, is the world's preeminent research and consulting firm in the field of competitive intelligence. Founded by Leonard Fuld, a pioneer and recognized leading authority in the field, Fuld & Company is a full-service competitive intelligence firm, providing research and analysis, strategic gaming, intelligence process consulting, and training to help clients understand the external competitive environment. The firm's mission is to help clients improve their performance by making better decisions through the application of solid intelligence on their markets and competitors. Additional information can be found at: www.fuld.com.


'/>"/>
SOURCE Fuld & Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
2. Myngle Best ICT Company at the European Ventures Summit
3. SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London
4. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
5. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
6. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
7. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
8. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
9. Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics
10. Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloittes 2008 Technology Fast 500
11. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... , ... Doctors in Italy, Japan, the UK and the US have reached ... gene and its link to malignant mesothelioma. Surviving Mesothelioma has just posted the details ... now. , The studies analyzed for the new report included more than 3,447 ...
(Date:5/27/2016)... At present, the Biotech sphere is in a ... volatility is what makes this industry interesting to consider. Here ... (NASDAQ: SNTA ), CTI BioPharma Corp. (NASDAQ: ... and Heat Biologics Inc. (NASDAQ: HTBX ). Sign ... these stocks at: http://www.activewallst.com/register/ ...
(Date:5/26/2016)... and READING, England , May ... http://www.indegene.com ), a leading global provider of clinical, ... and healthcare organisations and TranScrip ( http://www.transcrip-partners.com ), ... throughout the product lifecycle, today announced the extension ... IntraScience.      (Logo: http://photos.prnewswire.com/prnh/20141208/720248 ...
(Date:5/26/2016)... -- Despite the volatility that continues to envelop ... pre-market research on ActiveWallSt.com directs the investor community,s focus on ... RDUS ), Cerus Corp. (NASDAQ: CERS ), Arrowhead ... Therapeutics Inc. (NASDAQ: FPRX ). Register with us ... http://www.activewallst.com/ On Wednesday, shares in ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):